Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03192345
Title A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and REGN2810 in Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
Investigational Site Number :8400007 Duarte California 91010 United States Details
Investigational Site Number :8400004 Fairway Kansas 66205 United States Details
Investigational Site Number :8400001 Boston Massachusetts 02114 United States Details
Investigational Site Number :8400101 Boston Massachusetts 02115 United States Details
Investigational Site Number :8400008 Durham North Carolina 27710 United States Details
Investigational Site Number :8400006 Nashville Tennessee 37203 United States Details
Investigational Site Number :8400003 Dallas Texas 75230 United States Details
Investigational Site Number :0360002 Heidelberg West Victoria 3081 Australia Details
Investigational Site Number :0360001 Melbourne Victoria 3000 Australia Details
Investigational Site Number :0560002 Bruxelles 1200 Belgium Details
Investigational Site Number :0560001 Leuven 3000 Belgium Details
Investigational Site Number :1240003 Calgary Alberta T2N 4N2 Canada Details
Investigational Site Number :1240001 Toronto Ontario M5G 2M9 Canada Details
Investigational Site Number :1240002 Montreal Quebec H3T 1E2 Canada Details
Investigational Site Number :2330001 Tallinn 13419 Estonia Details
Investigational Site Number :2500006 Lille 59037 France Details
Investigational Site Number :2500002 Marseille 13385 France Details
Investigational Site Number :2500003 Nantes 44093 France Details
Investigational Site Number :2500005 Nantes 44093 France Details
Investigational Site Number :2500004 Paris 75010 France Details
Investigational Site Number :2500001 Villejuif 94800 France Details
Investigational Site Number :2760001 Essen 45122 Germany Details
Investigational Site Number :2760003 Hannover 30625 Germany Details
Investigational Site Number :3800003 Rozzano Milano 20089 Italy Details
Investigational Site Number :3800001 Milano 20133 Italy Details
Investigational Site Number :3800002 Milano 20141 Italy Details
Investigational Site Number :4100001 Seoul Seoul-teukbyeolsi 03080 Korea, Republic of Details
Investigational Site Number :4100002 Seoul Seoul-teukbyeolsi 138-736 Korea, Republic of Details
Investigational Site Number :5280005 Nijmegen 6525GA Netherlands Details
Investigational Site Number :5280001 Rotterdam 3015 GD Netherlands Details
Investigational Site Number :5280002 Utrecht 3584 CX Netherlands Details
Investigational Site Number :7240002 Barcelona Barcelona [Barcelona] 08003 Spain Details
Investigational Site Number :7240001 Barcelona Barcelona [Barcelona] 08035 Spain Details
Investigational Site Number :7240006 Barcelona Barcelona [Barcelona] 08036 Spain Details
Investigational Site Number :7240003 Madrid / Madrid Madrid, Comunidad De 28040 Spain Details
Investigational Site Number :7240004 Madrid / Madrid Madrid, Comunidad De 28050 Spain Details
Investigational Site Number :7240005 Pamplona Navarra 31008 Spain Details
Investigational Site Number :1580003 Kaohsiung 807 Taiwan Details
Investigational Site Number :1580002 Tainan 704 Taiwan Details
Investigational Site Number :1580001 Taipei 100 Taiwan Details
Investigational Site Number :8260001 Glasgow Central Bedfordshire G12 0YN United Kingdom Details
Investigational Site Number :8260002 Cardiff Vale Of Glamorgan, The CF14 2TL United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field